182 related articles for article (PubMed ID: 17220415)
1. Poly(D,L-lactide-coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice.
Lecaroz MC; Blanco-Prieto MJ; Campanero MA; Salman H; Gamazo C
Antimicrob Agents Chemother; 2007 Apr; 51(4):1185-90. PubMed ID: 17220415
[TBL] [Abstract][Full Text] [Related]
2. Intracellular killing of Brucella melitensis in human macrophages with microsphere-encapsulated gentamicin.
Lecároz C; Blanco-Prieto MJ; Burrell MA; Gamazo C
J Antimicrob Chemother; 2006 Sep; 58(3):549-56. PubMed ID: 16799160
[TBL] [Abstract][Full Text] [Related]
3. Nanocarriers with gentamicin to treat intracellular pathogens.
Lecaroz C; Gamazo C; Blanco-Prieto MJ
J Nanosci Nanotechnol; 2006; 6(9-10):3296-302. PubMed ID: 17048550
[TBL] [Abstract][Full Text] [Related]
4. Hydrophobic gentamicin-loaded nanoparticles are effective against Brucella melitensis infection in mice.
Imbuluzqueta E; Gamazo C; Lana H; Campanero MÁ; Salas D; Gil AG; Elizondo E; Ventosa N; Veciana J; Blanco-Prieto MJ
Antimicrob Agents Chemother; 2013 Jul; 57(7):3326-33. PubMed ID: 23650167
[TBL] [Abstract][Full Text] [Related]
5. Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes.
Prior S; Gander B; Lecároz C; Irache JM; Gamazo C
J Antimicrob Chemother; 2004 Jun; 53(6):981-8. PubMed ID: 15102748
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin.
Lecaroz C; Gamazo C; Renedo MJ; Blanco-Prieto MJ
J Microencapsul; 2006 Nov; 23(7):782-92. PubMed ID: 17123922
[TBL] [Abstract][Full Text] [Related]
7. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
Duvvuri S; Janoria KG; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
[TBL] [Abstract][Full Text] [Related]
8. Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice.
Prior S; Gander B; Irache JM; Gamazo C
J Antimicrob Chemother; 2005 Jun; 55(6):1032-6. PubMed ID: 15883176
[TBL] [Abstract][Full Text] [Related]
9. Release mechanisms from gentamicin loaded poly(lactic-co-glycolic acid) (PLGA) microparticles.
Friess W; Schlapp M
J Pharm Sci; 2002 Mar; 91(3):845-55. PubMed ID: 11920769
[TBL] [Abstract][Full Text] [Related]
10. Sterilization of gentamicin containing collagen/PLGA microparticle composites.
Friess W; Schlapp M
Eur J Pharm Biopharm; 2006 Jun; 63(2):176-87. PubMed ID: 16497493
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
Duvvuri S; Janoria KG; Mitra AK
J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
[TBL] [Abstract][Full Text] [Related]
12. Novel bioactive hydrophobic gentamicin carriers for the treatment of intracellular bacterial infections.
Imbuluzqueta E; Elizondo E; Gamazo C; Moreno-Calvo E; Veciana J; Ventosa N; Blanco-Prieto MJ
Acta Biomater; 2011 Apr; 7(4):1599-608. PubMed ID: 21115143
[TBL] [Abstract][Full Text] [Related]
13. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.
Prior S; Gamazo C; Irache JM; Merkle HP; Gander B
Int J Pharm; 2000 Feb; 196(1):115-25. PubMed ID: 10675713
[TBL] [Abstract][Full Text] [Related]
14. Effect of polymer blending on the release of ganciclovir from PLGA microspheres.
Duvvuri S; Gaurav Janoria K; Mitra AK
Pharm Res; 2006 Jan; 23(1):215-23. PubMed ID: 16320000
[TBL] [Abstract][Full Text] [Related]
15. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
[TBL] [Abstract][Full Text] [Related]
16. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model.
Oh YJ; Lee J; Seo JY; Rhim T; Kim SH; Yoon HJ; Lee KY
J Control Release; 2011 Feb; 150(1):56-62. PubMed ID: 21070826
[TBL] [Abstract][Full Text] [Related]
17. Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures.
Virto MR; Elorza B; Torrado S; Elorza Mde L; Frutos G
Biomaterials; 2007 Feb; 28(5):877-85. PubMed ID: 17064761
[TBL] [Abstract][Full Text] [Related]
18. Modifying the release of gentamicin from microparticles using a PLGA blend.
Friess W; Schlapp M
Pharm Dev Technol; 2002 May; 7(2):235-48. PubMed ID: 12066578
[TBL] [Abstract][Full Text] [Related]
19. MBG/PLGA composite microspheres with prolonged drug release.
Li X; Wang X; Zhang L; Chen H; Shi J
J Biomed Mater Res B Appl Biomater; 2009 Apr; 89(1):148-54. PubMed ID: 18777577
[TBL] [Abstract][Full Text] [Related]
20. Targeting Brucella melitensis with polymeric nanoparticles containing streptomycin and doxycycline.
Seleem MN; Jain N; Pothayee N; Ranjan A; Riffle JS; Sriranganathan N
FEMS Microbiol Lett; 2009 May; 294(1):24-31. PubMed ID: 19493005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
